SCHEMBL10227115

SCHEMBL10227115

Cc1ccc(-c2ccc3oc4c(-c5ccc6[nH]c7ccc(-c8cc(-c9ccc(C)cc9)cc9c8oc8ccc(-c%10ccc(C)cc%10)cc89)cc7c6c5)cc(-c5ccc(C)cc5)cc4c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CDK9 P50750 1/20 0.34
▸ DYRK1A Q13627 1/20 0.34
▸ DYRK2 Q92630 1/20 0.34
▸ KIF11 P52732 2/20 0.33
▸ ACHE P22303 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ICMT O60725 1/20 0.33
▸ CSNK2A2 P19784 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL788757 0.94 KIF11 (0.41) ALDH1A1MAPTNPC1RAB9AKDM4E
SCHEMBL10227381 0.88 ACHE (0.40) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL10226002 0.88 GAA (0.42) MAPTKDM4EMEN1KMT2ACSNK2A2
SCHEMBL10227111 0.88 GAA (0.42) MAPTKDM4EMEN1KMT2ACSNK2A2
SCHEMBL15746968 0.86 ADORA3 (0.32) ALDH1A1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL10227116 0.86 KIF11 (0.40) ALDH1A1MAPTNPC1RAB9ADYRK1A
SCHEMBL10226004 0.85 PIM1 (0.41) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL10226454 0.84 PIM1 (0.40) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL10226451 0.84 PIM1 (0.40) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD
SCHEMBL10226455 0.82 PLA2G2A (0.39) ALDH1A1MAPTSMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450188-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-09-20 — — US disclosed
US-20140145175-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-29 — — US disclosed
US-8642782-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 — — US disclosed
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SLC39A3, SULT1A1, NUTF2 ALDH1A1 1401/4885MAPT 1509/4885NPC1 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback